About

Skinopathy is a medical data & AI company that helps dermatology patients get the right treatment at the right time by arming physicians, nurses, and pharmacists with tools that enable them to screen, track, and manage skin conditions more effectively.

We currently serve over 2,200 physicians and 20,000 patients directly as well as pharmacies, long-term care operators, and hospitals in Ontario. We are also expanding across the globe, and will be launching our Asian, African, and South American presence in 2025.

We collaborate with payors and providers, NGOs, patient support programs and advocacy groups, as well as pharmaceuticals and cosmeceuticals.

The following are some of our accomplishments since inception.

• 2024 AIMed Conference Winner, Best Practitioner
• 2024 American Burns Association Carl A. Moyer Award recipient
• 2024 Chosen to represent Canada at the Startup World Cup (top 100 startups in the world)
• 2024 Named as a Top 20 Early Tech Company by the Canadian Innovation Exchange and Elevate
• 2023 LG announces at CES that Skinopathy is chosen as 1 of 40 startups in a field of over 2,200 to join them on their Mission for the Future
• 2023 Skinopathy is accepted as part of the exclusive Innovation, Science and Economic Canada (ISED) Accelerated Growth Services program
• 2023 Canadian Society of Plastic Surgery Conference First Prize for Innovation
• 2022 AIMed Conference Abstract Competition for originality, scholarship, and potential impact winner
• 2022 Nominated by Responsible AI Institute for Lead AI startup of the Year
• 2022 International INSEAD Business as a Force for Good Award winner
• 2022 2nd Place at the LG Nova Startup Competition in Silicon Valley